Susumu Hama Selected Research

Susumu Hama Research Topics

Disease

14	Neoplasms (Cancer) 05/2022 - 12/2002
6	Insulin Resistance 05/2014 - 01/2011
3	Melanoma (Melanoma, Malignant) 01/2020 - 03/2003
3	Fatty Liver 01/2013 - 01/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2014 - 11/2013
2	Iron Overload 01/2013 - 01/2013
2	Non-alcoholic Fatty Liver Disease 01/2013 - 10/2012
1	Colonic Neoplasms (Colon Cancer) 05/2022
1	Arthritis (Polyarthritis) 02/2022
1	Rheumatoid Arthritis 02/2022
1	Edema (Dropsy) 02/2022
1	Inflammation (Inflammations) 05/2014
1	Colorectal Neoplasms (Colorectal Cancer) 08/2013
1	Prostatic Neoplasms (Prostate Cancer) 08/2013
1	Hyperglycemia 01/2013
1	Alcoholic Fatty Liver 01/2013
1	Reperfusion Injury 01/2012
1	Sclerosis 01/2011
1	Obesity 01/2011
1	Breast Neoplasms (Breast Cancer) 05/2004

Drug/Important Bio-Agent (IBA)

4	Succinic Acid (Succinate)IBA 05/2022 - 05/2004
4	Peptides (Polypeptides)IBA 01/2017 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
3	Therapeutic UsesIBA 01/2017 - 08/2013
3	FructoseIBA 01/2013 - 10/2012
2	Tocopherols (Tocopherol)IBA 02/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2014
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2017 - 05/2015
2	Liposomes (Liposome)IBA 01/2017 - 01/2014
2	ResistinIBA 05/2014 - 11/2013
2	tamibaroteneIBA 01/2013 - 10/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013 - 10/2012
2	Insulin (Novolin)FDA Link 01/2013 - 10/2012
2	IronIBA 01/2013 - 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022
1	Interleukin-10 (Interleukin 10)IBA 05/2022
1	laminaranIBA 02/2022
1	alpha-tocopherol phosphateIBA 02/2022
1	Angiopoietin-2IBA 01/2020
1	AT1002IBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Drug CarriersIBA 01/2017
1	AntigensIBA 04/2015
1	NanogelsIBA 04/2015
1	Plasminogen Activator Inhibitor 1IBA 05/2014
1	Vitamin E FDA LinkGeneric 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	Nanoparticle Drug Delivery SystemIBA 01/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2014
1	Nucleic AcidsIBA 01/2014
1	Divalent CationsIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 11/2013
1	Selenious Acid (Selenite)IBA 08/2013
1	Selenic AcidIBA 08/2013
1	Dietary IronIBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	HepcidinsIBA 01/2013
1	Nonesterified Fatty Acids (NEFA)IBA 01/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013
1	Dietary Fats (Dietary Fat)IBA 01/2013
1	Advanced Glycation End ProductsIBA 01/2013
1	RetinoidsIBA 10/2012
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 10/2012
1	Leptin ReceptorsIBA 10/2012
1	LeptinIBA 10/2012
1	AntioxidantsIBA 01/2012
1	CPG-oligonucleotideIBA 03/2011
1	OligodeoxyribonucleotidesIBA 03/2011
1	AdipokinesIBA 01/2011
1	EstersIBA 05/2004
1	alpha-tocopheryl malonateIBA 05/2004
1	alpha-Tocopherol FDA Link 05/2004
1	gamma-TocopherolIBA 05/2004
1	alpha-tocopheryl nicotinateIBA 05/2004
1	alpha-tocopheryl oxalateIBA 05/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2002
1	Free RadicalsIBA 12/2002
1	Superoxides (Superoxide)IBA 12/2002

Therapy/Procedure

5	Therapeutics 01/2017 - 01/2014
2	Drug Therapy (Chemotherapy) 01/2014 - 01/2014
1	Intraperitoneal Injections 02/2022
1	Immunotherapy 03/2011
1	Intravenous Administration 03/2003